Business, energy, technology, markets and global industry news from Business News Today

Skip to content

Home
Pharma & Biotech
Medical Devices & Diagnostics
Features & Analysis

Home
Pharma & Biotech
Medical Devices & Diagnostics
Features & Analysis

Arensia Exploratory Medicine

PharmaDeviceNews Arensia Exploratory Medicine

Representative image of acute myeloid leukemia research as Moleculin Biotech’s Annamycin achieves 43% remission in interim Phase 2/3 MIRACLE trial results.

Pharma & Biotech

Annamycin leukemia trial progresses toward pivotal dose selection after encouraging interim results

by Soujanya Ravi
November 4, 2026
0 Comments

Moleculin Biotech's Annamycin shows 43% leukemia remission as MIRACLE data heads to ASH 2026. See what the early 2027 readout could reveal.

Read More

Latest news and features

FDA grants breakthrough designation to daridorexant following 50-minute sleep improvement in children
Pelareorep shows promising HPV-targeted immune activity as Oncolytics Biotech advances cancer research
Annamycin leukemia trial progresses toward pivotal dose selection after encouraging interim results
Kairos Pharma highlights 17.7-month progression-free survival with ENV-105 combination in metastatic prostate cancer
Bayer’s asundexian cut recurrent stroke risk by 26%, but can new AHA evidence strengthen its global approval prospects?
Imperative Care reports comparable 30-day outcomes for women and men in 106-patient pulmonary embolism analysis
EVX-01 personalized cancer vaccine moves into focus as Evaxion examines broader immune responses
PAS-004 advances toward Phase 2 as Pasithea seeks new treatment approach for cutaneous neurofibromas
T-Cypher Bio reports promising cancer cell killing with two next-generation T-cell engagers.
Trastuzumab pamirtecan slows breast cancer progression but raises interstitial lung disease concerns
Guardian Pharmacy Services has made another Tennessee acquisition, but can its local-first model sustain national growth?
Aarvik Therapeutics advances ARR-002 into Phase 1 and licenses two ADC candidates to Laurus Labs for India

POPULAR NEWS

plated Skin Science’s new BODY Serum brings platelet-derived exosome skincare beyond the face, targeting signs of aging, texture and hydration across the body. Representative image.

Pharma & Biotech

Rion Aesthetics expands plated Skin Science exosome platform with $338 BODY Serum

August 19, 2026

Pharma & Biotech

Omabit raises $2m to connect fragmented clinical evidence, but can AI improve drug development decisions?

October 27, 2026

Medical Devices & Diagnostics

Presage Technologies SmartSpectra cleared for contactless vital signs monitoring

July 8, 2026

Latest business and industry news

Vishay Intertechnology posts record $979m revenue as semiconductor demand drives margin recovery
Pfizer raises revenue outlook to $64bn as non-COVID medicines grow 7%
Pioneer Credit acquires A$206m debt portfolio for A$14.4m under new major bank agreement
Eaton sales jump 28% to $8.95bn as electrical backlog rises 46%
Uber bookings reach $59.8bn, but robotaxi spending and driver shortages test growth

TAGS

AstraZeneca clinical trials Eli Lilly and Company European Medicines Agency FDA FDA approval immunotherapy Inc. Johnson & Johnson medical devices non-small cell lung cancer oncology precision oncology U.S. Food and Drug Administration United States Food and Drug Administration

About PharmaDeviceNews
Disclaimer
Editorial Policy
Privacy Policy
Contact Us

© 2026 PharmaDeviceNews.com. All rights reserved.